Studienbeschreibung
TitelTitle: The AIM-HN and SEQ-HN Study: A 2 Cohort, Non-comparative, Pivotal Study Evaluating the Efficacy of Tipifarnib in Patients with Head and Neck Squamous Cell Carcinoma (HNSCC) with HRAS Mutations (AIM-HN) and the Impact of HRAS Mutations on Response to First Line Systemic Therapies for HNSCC (SEQ-HN).
KurztitelKura KO-TIP 007
EudraCT-Nr.2018-001437-40
Wissenschaftliche KurzbeschreibungA Pivotal Study of Tipifarnib in Patients with Recurrent or Metastatic Head and Neck Squamous Cell
Carcinoma (HNSCC) with HRAS mutations who have Failed At least One Prior Line of Therapy
Untersuchte Krankheit, Gesundheitsproblem
ICD-Code- C10.0 - Vallecula epiglottica
Charakteristika
StudientypInterventionell
StudienphaseII